Teresa Fernandez-Lopez

Teresa Fernandez-Lopez

Oncology

Castellana, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 146 publications

Cardiovascular disease, cancer risk, and sex: expanding the prevention agenda in cardio-oncology.

Cardiovascular disease, cancer risk, and sex: expanding the prevention agenda in cardio-oncology.

Journal: European heart journal

Published: August 11, 2026

Long-term mortality and acute complications after percutaneous pericardiocentesis in cancer and noncancer patients presenting with severe pericardial effusion.

Long-term mortality and acute complications after percutaneous pericardiocentesis in cancer and noncancer patients presenting with severe pericardial effusion.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: April 22, 2026

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.

Journal: Cancers

Published: April 01, 2026

NOD1 is a key mediator of atrial myopathy in heart failure.

NOD1 is a key mediator of atrial myopathy in heart failure.

Journal: Theranostics

Published: March 19, 2026

Asymptomatic atrial fibrillation in patients treated with BTK inhibitors in hematologic malignancies: a systematic review and metanalysis.

Asymptomatic atrial fibrillation in patients treated with BTK inhibitors in hematologic malignancies: a systematic review and metanalysis.

Journal: European journal of internal medicine

Published: March 12, 2026

SEMERGEN Position Statement on the management of the Oncologic Patient: Comprehensive Approach to Cardiotoxicity in Primary Care

SEMERGEN Position Statement on the management of the Oncologic Patient: Comprehensive Approach to Cardiotoxicity in Primary Care

Journal: Semergen

Published: March 10, 2026

Heart failure, infarction, and the seed of malignancy: stepping into the era of reverse cardio-oncology.

Heart failure, infarction, and the seed of malignancy: stepping into the era of reverse cardio-oncology.

Journal: European journal of heart failure

Published: March 03, 2026

Primary prophylaxis of venous thromboembolism in ambulatory patients with active cancer.

Primary prophylaxis of venous thromboembolism in ambulatory patients with active cancer.

Journal: European heart journal

Published: February 18, 2026

The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology.

The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology.

Journal: European heart journal

Published: January 23, 2026

Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients: MATRIX Study.

Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients: MATRIX Study.

Journal: JACC. CardioOncology

Published: January 15, 2026

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments. A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments. A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Journal: European heart journal. Cardiovascular Imaging

Published: December 01, 2025

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Journal: European heart journal. Cardiovascular Imaging

Published: December 01, 2025

Showing 1-12 of 146

Last Updated: 09/26/2026